Alex Blyth to speak at Rejuvenation Startup Summit 2022
We are happy to announce Alex Blyth, Founder and CEO of LIfT BioSciences, as a speaker for the Rejuvenation Startup Summit 2022. Also meet Dr. Oxana Polyakova, LIfT’s CSO at the networking forum of the summit.
LIfT BioSciences is committed to developing the world’s first ‘off-the-shelf’ cell therapy to destroy all solid tumours, irrespective of strain or mutation. LIfT is currently completing pre-clinical work before running a first-in-human clinical trial to demonstrate remission in high unmet need solid tumours by 2023, including pancreatic cancer.
Alex Blyth is a serial entrepreneur, inventor and conceptual biologist with 20 years’ experience in bringing over 50 novel biopharma therapies to market for companies like Pfizer, Allergan, abbVie, Amgen, Shire, Takeda, GSK & Sanofi. Alex founded LIfT after losing his mother to Pancreatic Cancer, and seeing a new way to beat cancer by giving patients the immunity of those who are innately resistant to cancer.
Alex is Founder and CEO of LIfT BioSciences
Dr. Oxana Polyakova, in over a 20-year career to date, has worked across multiply therapeutic modalities in both pharma and biotech settings, with significant experience discovering biologics for Oncology indications. Oxana specialises in successfully bringing cell therapies to clinic. Oxana was a founding scientist for cell therapy company GammaDelta Therapeutics before moving to lead discovery at Adaptate Biotherapeutics. Oxana holds a PhD from Moscow State University.
Oxana is CSO of LIfT BioSciences.
About the Rejuvenation Startup Summit 2022
The Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) hosted by the Forever Healthy Foundation, is a vibrant networking event that aims to accelerate the development of the rejuvenation biotech industry.
Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself. Rejuvenation therapies aim to reverse or repair age-related cellular changes such as molecular waste, calcification, tissue stiffening, loss of stem cell function, genetic alterations, and impaired energy production.
The Rejuvenation Summit brings together startups, members of the longevity venture capital / investor ecosystem, and researchers interested in founding or joining a startup – all aiming to create therapies to vastly extend the healthy human lifespan.
Further information can be found at www.forever-healthy.org/summit/
About LIfT BioSciences
LIfT Biosciences is a Biotech bringing to market a 1st in class allogeneic innate cell therapy called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). N-LIfT uses a special type of N1a neutrophil with special cancer killing and immune recruitment capabilities. Our vision is to develop the world’s first cell bank of mass produced ‘cancer killing neutrophils’ to deliver a portfolio of immuno-oncology cell therapies for delivering complete remission in all solid tumours.
Further information can be found at www.liftbiosciences.com